American Society for Radiation Oncology (ASTRO) survey of radiation biology educators in U.S. and Canadian radiation oncology residency programs.

Department of Radiation Oncology, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, USA.
International journal of radiation oncology, biology, physics (Impact Factor: 4.18). 10/2009; 75(3):896-905. DOI: 10.1016/j.ijrobp.2009.05.009
Source: PubMed

ABSTRACT To obtain, in a survey-based study, detailed information on the faculty currently responsible for teaching radiation biology courses to radiation oncology residents in the United States and Canada.
In March-December 2007 a survey questionnaire was sent to faculty having primary responsibility for teaching radiation biology to residents in 93 radiation oncology residency programs in the United States and Canada.
The responses to this survey document the aging of the faculty who have primary responsibility for teaching radiation biology to radiation oncology residents. The survey found a dramatic decline with time in the percentage of educators whose graduate training was in radiation biology. A significant number of the educators responsible for teaching radiation biology were not fully acquainted with the radiation sciences, either through training or practical application. In addition, many were unfamiliar with some of the organizations setting policies and requirements for resident education. Freely available tools, such as the American Society for Radiation Oncology (ASTRO) Radiation and Cancer Biology Practice Examination and Study Guides, were widely used by residents and educators. Consolidation of resident courses or use of a national radiation biology review course was viewed as unlikely by most programs.
A high priority should be given to the development of comprehensive teaching tools to assist those individuals who have responsibility for teaching radiation biology courses but who do not have an extensive background in critical areas of radiobiology related to radiation oncology. These findings also suggest a need for new graduate programs in radiobiology.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background:The clinical development of new drugs with radiation appears to be limited. We hypothesised that phase I clinical trials with radiation therapy (RT) are initiated too late into a new drug's lifetime, impeding the ability to complete RT-drug development programmes before patent expiration.Methods:We identified novel drug-radiation phase I combination trials performed between 1980 and 2012 within the PubMed and databases. Data gathered for each drug included: date the initial phase I trial with/without RT was opened/published, date of the published positive phase III trials, and patent expiration dates. Lag time was defined as the interval between opening of the phase I trial without RT and the opening of the phase I with RT. Linear regression was used to model how the lag time has changed over time.Results:The median lag time was 6 years. The initial phase I trial with RT was typically published 2 years after the first published positive phase III trial and 11 years before patent expiration. Using a best-fit linear model, lag time decreased from 10 years for phase I trials published in 1990 to 5 years in 2005 (slope significantly non-zero, P<0.001).Conclusions:Clinical drug development with RT commences late in the life cycle of anti-cancer agents. Taking into account the additional time required for late-phase clinical trials, the delay in initiating clinical testing of drug-RT combinations discourages drug companies from further pursuing RT-based development. Encouragingly, lag time appears to be decreasing. Further reduction in lag time may accelerate RT-based drug development, potentially improving patient outcomes.British Journal of Cancer advance online publication, 12 August 2014; doi:10.1038/bjc.2014.448.
    International Journal of Radiation OncologyBiologyPhysics 08/2014; 111(7). DOI:10.1038/bjc.2014.448 · 4.18 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aims and background. To present the Italian state-of-the-art contribution to radiobiology of external beam radiotherapy, brachytherapy, and radionuclide radiotherapy. Methods and study design. A survey of the literature was carried out, using PubMed, by some independent researchers of the Italian group of radiobiology. Each paper was reviewed by researchers of centers not comprising its authors. The survey was limited to papers in English published over the last 20 years, written by Italian investigators or in Italian institutions, excluding review articles. Results. A total of 135 papers have been published in journals with an impact factor, with an increase in the number of published papers over time, for external beam radiotherapy rather than radionuclide radiotherapy. The quantity and quality of the papers researched constitutes a proof of the enduring interest in clinical radiobiology among Italian investigators. Conclusions. The survey could be useful to individuate expert partners for an Italian network on clinical radiobiology, addressing future collaborative investigations.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The sustainability of radiation biology (radiobiology) is under threat in South Africa because of underdevelopment in the discipline, despite the fact that South Africa has been a user of radiation since radioactivity and X-rays were discovered. The widespread use of radiation in medicine, nuclear reactors, particle accelerators and other sophisticated nuclear facilities in South Africa makes it imperative that the interaction of radiation with biological systems is understood. For example, radiobiology is critical in radiation oncology and cancer treatment. Radiobiology is a distinctly biological science and its uniqueness and value should be highlighted to provide insight for authorities and other relevant parties. Regrettably, radiobiology has been largely neglected despite the importance of maintaining expertise and competence in this discipline. Many radiation-associated disciplines require radiobiology for their training and practice yet few radiobiologists are available nationally. The scientific community needs to be informed of the predicament of radiobiology in South Africa so that the situation can be addressed. Radiobiology is a scarce skill that needs to be developed to support South Africa's mature radiation infrastructure. The country has too few radiobiologist training programmes and there is a lack of succession planning. Radiobiology is required for training and practice in a number of disciplines that use radiation, but, as a result of a shortage of qualified personnel, teaching of radiobiology has frequently been conducted by non-experts. To reinvigorate radiobiology in South Africa, a collective effort by government, academia, industry and allied professionals is required.
    South African Journal of Science 12/2011; 108(7-8):33-43. DOI:10.4102/sajs.v108i7/8.972 · 1.03 Impact Factor

Full-text (2 Sources)

Available from
May 29, 2014